A. Stratmann et al., CELL-TYPE-SPECIFIC EXPRESSION OF ANGIOPOIETIN-1 AND ANGIOPOIETIN-2 SUGGESTS A ROLE IN GLIOBLASTOMA ANGIOGENESIS, The American journal of pathology, 153(5), 1998, pp. 1459-1466
Glioblastomas are highly vascular tumors which overexpress the angioge
nesis factor vascular endothelial growth factor (VEGF), VEGF and its r
eceptors, VEGF-R1 and VEGF-R2, have been shown to be necessary for emb
ryonic angiogenesis as well as for turner angiogenesis. Recently, the
angiopoietin/Tie2 receptor system has been shown to exert functions in
the cardiovascular system that are distinct from VEGF but are also cr
itical for normal vascular development. To assess the potential role o
f Tie2 and its ligands angiopoietin-1 and angiopoietin-2 in tumor vasc
ularization, we analyzed their expression pattern in human gliomas, Ti
e-2 was up-regulated in tumor endothelium compared to normal human bra
in tissue. We further observed cell type-specific up-regulation of the
message for both angiopoietin-1 and angiopoietin-2 in gliomas, Wherea
s Ang-1 mRNA was expressed in tumor cells, Ang-2 mRNA was detected in
endothelial cells of a subset of glioblastoma blood vessels. Small cap
illaries with few periendothelial support cells showed strong expressi
on of Angiopoietin-2, whereas larger glioblastoma vessels with many pe
riendothelial support cells showed little or no expression. Although t
he function of Tie2 and its ligands in tumor angiogenesis remains a su
bject of speculation, our findings are in agreement with a recently pr
oposed hypothesis that in the presence of VEGF, local production of An
g-2 might promote angiogenesis.